1
|
Kumaraswamy B, Hemalatha K, Pal R, Matada GSP, Hosamani KR, Aayishamma I, Aishwarya NVSS. An insight into sustainable and green chemistry approaches for the synthesis of quinoline derivatives as anticancer agents. Eur J Med Chem 2024; 275:116561. [PMID: 38870832 DOI: 10.1016/j.ejmech.2024.116561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2024] [Revised: 05/12/2024] [Accepted: 05/31/2024] [Indexed: 06/15/2024]
Abstract
Quinolones, a key class of heterocyclics, are gaining popularity among organic and medicinal chemists due to their promising properties. Quinoline, with its broad spectrum of action, plays a primordial role in chemotherapy for cancer. Drugs include lenvatinib and its structural derivatives carbozantinib and bosutinib, and tipifarnib are the popular anticancer agents. Owing to the importance of quinoline, there are several classical methods for the synthesis such as, such as Gould-Jacobs, Conrad-Limpach, Camps cyclization, Skraup, Doebnervon Miller, Combes, Friedlander, Pfitzinger, and Niementowski synthesis. These methods are well-commended for developing an infinite variety of quinoline analogues. However, these procedures are associated with several drawbacks such as long reaction times, use of hazardous chemicals or stoichiometric proportions, difficulty of working up conditions, high temperatures, organic solvents, and the presence of numerous steps, all of which have an impact on the environment and the economy. As a result, researchers are working hard to develop green quinoline compounds in the hopes of making groundbreaking discoveries in the realm of cancer. In this review, we have highlighted significant research on quinoline-based compounds and their structure-activity relationship (SAR). Furthermore, because of the significant economic and environmental health and safety (EHS) concerns, more research is being dedicated to the green synthesis of quinolone derivatives. The current review offers recent advances in quinoline derivatives as anticancer agents for green synthesis using microwave, ultrasound, and one-pot synthesis. We believe that our findings will provide useful insight and inspire more green research on this framework to produce powerful and selective quinoline derivatives.
Collapse
Affiliation(s)
- B Kumaraswamy
- Integrated Drug Discovery Centre, Department of Pharmaceutical Chemistry, Acharya & BM Reddy College of Pharmacy, Bengaluru, 560107, Karnataka, India
| | - K Hemalatha
- Integrated Drug Discovery Centre, Department of Pharmaceutical Chemistry, Acharya & BM Reddy College of Pharmacy, Bengaluru, 560107, Karnataka, India.
| | - Rohit Pal
- Integrated Drug Discovery Centre, Department of Pharmaceutical Chemistry, Acharya & BM Reddy College of Pharmacy, Bengaluru, 560107, Karnataka, India.
| | - Gurubasavaraja Swamy Purawarga Matada
- Integrated Drug Discovery Centre, Department of Pharmaceutical Chemistry, Acharya & BM Reddy College of Pharmacy, Bengaluru, 560107, Karnataka, India.
| | - Ketan R Hosamani
- Integrated Drug Discovery Centre, Department of Pharmaceutical Chemistry, Acharya & BM Reddy College of Pharmacy, Bengaluru, 560107, Karnataka, India
| | - I Aayishamma
- Integrated Drug Discovery Centre, Department of Pharmaceutical Chemistry, Acharya & BM Reddy College of Pharmacy, Bengaluru, 560107, Karnataka, India
| | | |
Collapse
|
2
|
A Majed A, Al-Duhaidahawi D, A Omran H, Abbas S, S Abid D, Y Hmood A. Synthesis, molecular docking of new amide thiazolidine derived from isoniazid and studying their biological activity against cancer cells. J Biomol Struct Dyn 2023:1-12. [PMID: 37922154 DOI: 10.1080/07391102.2023.2276313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2023] [Accepted: 10/07/2023] [Indexed: 11/05/2023]
Abstract
BCL2, an antiapoptotic protein, is overexpressed in many cancers, making it a good cancer treatment target. In 30 years, few BCL2 targeting agents have shown clinical significance. This work designed new amide thiazolidine derived from isoniazid targeting BCL2 and tested them on cancer cell lines, for binding affinities, the novel candidates were docked to the BCL2 target receptor. IC50 of compound A8 46.67 ± 0.9 and 57.14 ± 0.88 μg/ml against PC3 and HEPG2 respectively with docking score -7.6 Kcal/mol with 6GL8 make it the best compound in this series. Melting point, FT-IR, elemental microanalysis (CHN), 1HNMR, and 13CNMR confirmed chemical structures.Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
- Ahmed A Majed
- College of Education, Department of Chemistry, Basrah University, Basrah, Iraq
- Education Directorate of Thi-Qar, Ministry of Education, Thi-Qar, Iraq
| | | | - Haider A Omran
- Education Directorate of Basrah, Ministry of Education, Basrah, Iraq
| | - Sabah Abbas
- College of Pharmacy, University of Kufa, AL-Najaf, Iraq
| | - Dawood S Abid
- College of Education for Pure Sciences, Department of Chemistry, Basrah University, Basrah, Iraq
| | - Ahmed Y Hmood
- Department of Marine Environmental Chemistry, Marine Science Center, University of Basrah, Basrah, Iraq
| |
Collapse
|
3
|
Novel hybrid molecules based on triazole-quinoline as potential anticancer agents: screening on MCF-7 cell line, docking studies, and pharmacokinetics evaluation. JOURNAL OF THE IRANIAN CHEMICAL SOCIETY 2023. [DOI: 10.1007/s13738-022-02737-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
4
|
Badithapuram V, Nukala SK, Thirukovela NS, Dasari G, Manchal R, Bandari S. Design, Synthesis, and Molecular Docking Studies of Some New Quinoxaline Derivatives as EGFR Targeting Agents. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY 2022; 48:565-575. [PMID: 35757285 PMCID: PMC9212206 DOI: 10.1134/s1068162022030220] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Revised: 09/13/2021] [Accepted: 10/11/2021] [Indexed: 11/23/2022]
Abstract
The synthesis of some new quinoxaline derivatives (IVa-n) and their structure determination using 1H NMR, 13C NMR and mass spectral analysis was described herein. The in vitro anti-cancer activity of the these compounds (IVa-n) revealed that the compound1-((1-(4-bromophenyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(tetrazolo[1,5-a]quinoxalin-4-yl)pyrazolidine-3,5-dione (IVd) has shown promising activity, whereas, compounds 1-((1-phenyl-1H-1,2,3-triazol-4-yl)methyl)-2-(tetrazolo[1,5-a]quinoxalin-4-yl)pyrazolidine-3,5-dione (IVa), 1-(tetrazolo[1,5-a]quinoxalin-4-yl)-2-((1-(m-tolyl)-1H-1,2,3-triazol-4-yl)methyl)pyrazolidine-3,5-dione (IVb), 1-((1-(3,5-dimethoxyphenyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(tetrazolo[1,5-a]quinoxalin-4-yl)pyrazolidine-3,5-dione (IVh) and 1-((1-(4-nitrophenyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(tetrazolo[1,5-a]quinoxalin-4-yl)pyrazolidine-3,5-dione (IVi) exhibited good to moderate activity against four human cancer cell lines such as HeLa, MCF-7, HEK 293T, and A549 as compared to the doxorubicin. Predominantly, the compound displayed excellent activity over HeLa, MCF-7, HEK 293T, and A549 with IC50 values of 3.20 ± 1.32, 4.19 ± 1.87, 3.59 ± 1.34, and 5.29 ± 1.34 μM, respectively. Moreover, molecular docking studies of derivatives (IVa-n) on EGFR receptor suggested that the most potent compound strongly binds to protein EGFR (pdbid:4HJO) and the energy calculations of in silico studies were also in good agreement with the obtained IC50 values. Supplementary Information The online version contains supplementary material available at 10.1134/S1068162022030220.
Collapse
Affiliation(s)
- Vinitha Badithapuram
- Department of Chemistry, Chaitanya (Deemed to be University), 506001 Warangal, Telangana, India
| | - Satheesh Kumar Nukala
- Department of Chemistry, Chaitanya (Deemed to be University), 506001 Warangal, Telangana, India
| | | | - Gouthami Dasari
- Department of Chemistry, Chaitanya (Deemed to be University), 506001 Warangal, Telangana, India
| | - Ravinder Manchal
- Department of Chemistry, Chaitanya (Deemed to be University), 506001 Warangal, Telangana, India
| | - Srinivas Bandari
- Department of Chemistry, Chaitanya (Deemed to be University), 506001 Warangal, Telangana, India
| |
Collapse
|
5
|
Xinyi W, Shiqi X, Shishuo C, Yumin S, Jun W. 1,2,3-Triazole derivatives with anti-breast cancer potential. Curr Top Med Chem 2022; 22:1406-1425. [DOI: 10.2174/1568026622666220415225334] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2022] [Revised: 03/03/2022] [Accepted: 03/03/2022] [Indexed: 11/22/2022]
Abstract
Abstract:
Breast cancer is one of the most prevalent malignant diseases and one of the main mortality causes among women across the world. Despite advances in chemotherapy, drug resistance remains major clinical concerns, creating an urgent need to explore novel anti-breast cancer drugs. 1,2,3-Triazole is a privileged moiety, and its derivatives could inhibit cancer cell proliferation, and induce the cell cycle arrest and apoptosis. Accordingly, 1,2,3-triazole derivatives possess profound activity against various cancers including breast cancer. This review summarizes the latest progresses related to the anti-breast cancer potential of 1,2,3-triazole derivatives, covering articles published from January 2017 to December 2021. The mechanisms of action and structure-activity relationships (SARs) are also discussed for further rational design of more effective candidates.
Collapse
Affiliation(s)
- Wu Xinyi
- School of Nuclear Technology and Chemistry & Biology, Hubei University of Science and Technology, Xianning, 437100, China
| | - Xia Shiqi
- School of Nuclear Technology and Chemistry & Biology, Hubei University of Science and Technology, Xianning, 437100, China
| | - Cheng Shishuo
- School of Nuclear Technology and Chemistry & Biology, Hubei University of Science and Technology, Xianning, 437100, China
| | - Shi Yumin
- School of Nuclear Technology and Chemistry & Biology, Hubei University of Science and Technology, Xianning, 437100, China
| | - Wang Jun
- School of Nuclear Technology and Chemistry & Biology, Hubei University of Science and Technology, Xianning, 437100, China
| |
Collapse
|
6
|
Kappenberg YG, Stefanello FS, Zanatta N, Martins MAP, Nogara PA, Rocha JBT, Tisoco I, Iglesias BA, Bonacorso HG. Hybridized 4-Trifluoromethyl-(1,2,3-triazol-1-yl)quinoline System: Synthesis, Photophysics, Selective DNA/HSA Bio-interactions and Molecular Docking. Chembiochem 2021; 23:e202100649. [PMID: 34878702 DOI: 10.1002/cbic.202100649] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2021] [Revised: 12/07/2021] [Indexed: 11/10/2022]
Abstract
The synthesis, structural analysis, and evaluation of the photophysical properties of twelve novel 2-aryl(heteroaryl)-6-(4-alkyl(aryl)-1H-1,2,3-triazol-1-yl)-4-(trifluoromethyl)quinolines (6-8), where aryl(heteroaryl)=Ph, 4-Me-C6 H4 , 4-F-C6 H4 and 2- furyl; 4-alkyl(aryl)=-CH2 OH, -(CH2 )5 CH3 and Ph, are reported. Hybrid scaffolds 6-8 were synthesized at 77-95 % yields by regioselective copper-catalysed azide-alkyne cycloaddition (CuAAC) reaction of unpublished 6-azido-4-(trifluoromethyl)quinolines (2) with selected terminal alkynes (3-5). Azido intermediates 2 were obtained from the reaction of 6-amino-4-(trifluoromethyl)quinolines (1) and sodium azide at good yields (78-87 %). Compounds 6-8 were structurally fully characterized by 1 H-, 13 C- and 19 F- and 1 H-13 C 2D-NMR (HSQC, HMBC) spectroscopy, X-ray diffraction (SC-XRD) and HRMS analysis. Moreover, the photophysical properties, DNA- and HSA-binding experiments (bio-interactions), and molecular docking studies for compounds 6-8 were performed. These are discussed and compared with similar compounds from recent research.
Collapse
Affiliation(s)
- Yuri G Kappenberg
- Núcleo de Química de Heterociclos (NUQUIMHE) Departamento de Química, Universidade Federal de Santa Maria, 97105-900 -, Santa Maria, RS, Brazil
| | - Felipe S Stefanello
- Núcleo de Química de Heterociclos (NUQUIMHE) Departamento de Química, Universidade Federal de Santa Maria, 97105-900 -, Santa Maria, RS, Brazil
| | - Nilo Zanatta
- Núcleo de Química de Heterociclos (NUQUIMHE) Departamento de Química, Universidade Federal de Santa Maria, 97105-900 -, Santa Maria, RS, Brazil
| | - Marcos A P Martins
- Núcleo de Química de Heterociclos (NUQUIMHE) Departamento de Química, Universidade Federal de Santa Maria, 97105-900 -, Santa Maria, RS, Brazil
| | - Pablo A Nogara
- Departamento de Bioquímica e Biologia Molecular, Universidade Federal de Santa Maria, 97105-900, Santa Maria, RS, Brazil
| | - João B T Rocha
- Departamento de Bioquímica e Biologia Molecular, Universidade Federal de Santa Maria, 97105-900, Santa Maria, RS, Brazil
| | - Isadora Tisoco
- Laboratório de Bioinorgânica e Materiais Porfirínicos Departamento de Química, Universidade Federal de Santa Maria, 97105-900 -, Santa Maria, RS, Brazil
| | - Bernardo A Iglesias
- Laboratório de Bioinorgânica e Materiais Porfirínicos Departamento de Química, Universidade Federal de Santa Maria, 97105-900 -, Santa Maria, RS, Brazil
| | - Helio G Bonacorso
- Núcleo de Química de Heterociclos (NUQUIMHE) Departamento de Química, Universidade Federal de Santa Maria, 97105-900 -, Santa Maria, RS, Brazil
| |
Collapse
|
7
|
Alam MM. 1,2,3-Triazole hybrids as anticancer agents: A review. Arch Pharm (Weinheim) 2021; 355:e2100158. [PMID: 34559414 DOI: 10.1002/ardp.202100158] [Citation(s) in RCA: 80] [Impact Index Per Article: 26.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2021] [Revised: 08/03/2021] [Accepted: 09/04/2021] [Indexed: 12/25/2022]
Abstract
Despite the advancements in the development of anticancer agents, more effective and safer anticancer drugs still need to be developed as the current agents cause unwanted side effects and many patients have become drug resistant. 1,2,3-Triazoles, due to their remarkable biological potential, have received considerable attention in drug discovery for the development of anticancer agents. The present review article presents an overview of the recent advances in 1,2,3-triazole hybrids with anticancer potential over the last 2 years, their chemical structures, structure-activity relationships, and mechanisms of action, as well as insights into the docking studies.
Collapse
Affiliation(s)
- Mohammad Mahboob Alam
- Department of Chemistry, Faculty of Science, Albaha University, Albaha, Kingdom of Saudi Arabia
| |
Collapse
|
8
|
Nural Y, Ozdemir S, Yalcin MS, Demir B, Atabey H, Ece A, Seferoglu Z. Synthesis, Biological Evaluation, Molecular Docking, and Acid Dissociation Constant of New Bis‐1,2,3‐triazole Compounds. ChemistrySelect 2021. [DOI: 10.1002/slct.202101148] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
- Yahya Nural
- Department of Analytical Chemistry Faculty of Pharmacy Mersin University Mersin, TR 33169 Turkey
- Advanced Technology Research and Application Center Mersin University Mersin, TR 33343 Turkey
| | - Sadin Ozdemir
- Food Processing Programme Technical Science Vocational School Mersin University Mersin, TR 33343 Turkey
| | - Mustafa Serkan Yalcin
- Department of Chemistry and Chemical Processing Technologies Technical Science Vocational School Mersin University Mersin, TR 33343 Turkey
| | - Bunyamin Demir
- Advanced Technology Research and Application Center Mersin University Mersin, TR 33343 Turkey
- Department of Mechanical Engineering, orgDiv/>Faculty of Engineering Mersin University Mersin, TR 33169 Turkey
| | - Hasan Atabey
- Mersin National Education Directorate Department of Analytical Chemistry Mersin Turkey
| | - Abdulilah Ece
- Department of Phaarmaceutical Chemistry Faculty of Pharmacy Biruni University Istanbul 34010 Turkey
| | - Zeynel Seferoglu
- Department of Chemistry Faculty of Science Gazi University,Yenimahalle Ankara, TR 06560 Turkey
| |
Collapse
|
9
|
Panda P, Chakroborty S. Navigating the Synthesis of Quinoline Hybrid Molecules as Promising Anticancer Agents. ChemistrySelect 2020. [DOI: 10.1002/slct.202002790] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Pravati Panda
- Department of Chemistry Rama Devi Women's University Bhubaneswar, Odisha 751004 India
| | | |
Collapse
|